dewpointx.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $295.48MM
Dewpoint Therapeutics translates condensate biology into treatments for the toughest diseases.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/03/2022 | Series C | $150MM | $xx.xx | $469.11MM | 3e Bioventures Capital, Arch Venture Partners, Bayer, Ecor1 Capital, General Catalyst, Maverick Ventures, Mirae Asset Capital, Mubadala Capital, Ns Investment, Polaris Partners, Samsara Biocapital, Softbank | |
Price per Share
$xx.xx
Shares Outstanding
62,714,269
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
3e Bioventures Capital, Arch Venture Partners, Bayer, Ecor1 Capital, General Catalyst, Maverick Ventures, Mirae Asset Capital, Mubadala Capital, Ns Investment, Polaris Partners, Samsara Biocapital, Softbank
|
||||||
09/29/2020 | Series B | $77.2MM | $xx.xx | $283.16MM | Arch Venture Partners, Bellco Capital, Ecor1 Capital, Innovation Endeavors, Leaps By Bayer, Maverick Ventures, Polaris Partners, Samsara Biocapital | |
Price per Share
$xx.xx
Shares Outstanding
36,499,989
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arch Venture Partners, Bellco Capital, Ecor1 Capital, Innovation Endeavors, Leaps By Bayer, Maverick Ventures, Polaris Partners, Samsara Biocapital
|
||||||
01/30/2019 | Series A-1 | $5MM | $xx.xx | $124.52MM | 6 Dimensions Capital, Alexandria Venture Investors, Ecor1 Capital, Leaps By Bayer, Polaris Partners, Samsara Biocapital | |
Price per Share
$xx.xx
Shares Outstanding
4,166,666
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
6 Dimensions Capital, Alexandria Venture Investors, Ecor1 Capital, Leaps By Bayer, Polaris Partners, Samsara Biocapital
|
||||||
01/30/2019 | Series A | $63.28MM | $xx.xx | $124.52MM | 6 Dimensions Capital, Alexandria Venture Investors, Ecor1 Capital, Leaps By Bayer, Polaris Partners, Samsara Biocapital | |
Price per Share
$xx.xx
Shares Outstanding
63,283,217
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
6 Dimensions Capital, Alexandria Venture Investors, Ecor1 Capital, Leaps By Bayer, Polaris Partners, Samsara Biocapital
|